NewAmsterdam Pharma financial statements

뉴암스테르담 파머NASDAQ:NAMS · Nasdaq · Healthcare · sector #17
$22.27-2.32%
2026-10-06 close

NewAmsterdam Pharma's published financial data is dated 2026-10-04. 2024 revenue was $46M. 2024 operating profit was −$176M.

Reported results

NewAmsterdam Pharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy